The Bleeding Patient on Anti-thrombotic Therapy: How Should the Transfusion Service Respond?
Program Code: 9412-TC
Tuesday, October 27, 2009
10:30 AM to 12:00 PM (ET)

MODERATOR
Kenneth D. Friedman, MD, Blood Center of Southeastern Wisconsin

SPEAKERS
Jonathan Waters, MD, Magee Womens Hosp. of Univ. of Pitts. Med. Center
Arthur Bracey, MD, St. Luke's Episocopal Hospital/Texas Heart Institu
Mark Crowther, MD, MSc, FRCPC, McMaster University

DESCRIPTION
Transfusion Services are commonly asked to provide advice and/or blood products in order to acutely reverse the effects of antithrombotic therapy. Multiple factors influence the choice of intervention, including the patient's clinical situation, the mechanism of action of the patient's antithrombotic therapy, the extent of antithrombotic effect at the time the patient presents, and whether a specific agent or non-specific agent is available to antagonize the antithrombotic agent. In this session, cases will be used to highlight key issues related to urgent reversal of vitamin-K antagonist medication, management of bleeding or perioperative patients receiving antiplatelet agents, and the use of near-patient testing to guide hemostatic support in the surgical suite.